Milestone Pharmaceuticals Inc. 8-K

What Happened

• On May 13, 2026, Milestone Pharmaceuticals Inc. (MIST) announced its financial results for the quarter ended March 31, 2026 and other business highlights via a press release. The press release is furnished as Exhibit 99.1 to the Form 8‑K and is incorporated by reference.

Key Details

• Filing date: May 13, 2026.
• Reporting period: Quarter ended March 31, 2026.
• Press release attached as Exhibit 99.1 to the Form 8‑K.
• The Form 8‑K did not report other items such as executive changes, mergers, or bankruptcy.

Why It Matters

• This filing signals that Milestone’s latest quarterly earnings, revenue and other operational updates are now public; investors should review the attached press release for the specific financial figures, cash position, and program updates.
• Because the 8‑K only furnishes the press release, the detailed financial metrics and any forward‑looking statements will be found in Exhibit 99.1—important for assessing near‑term performance and company progress on clinical or business initiatives.